Overview

Price chart · mood · technical indicators

BIAF

bioAffinity Technologies, Inc.stock Healthcare

Diagnostics & Research

$0.8488.20%Current Market Mood:Strong Bearish

Market Mood

Price Range (1Y)

$0.69$13.80

Current: $0.84

Market Comparison

vs Healthcare Sector & Diagnostics & Research Industry

BIAF

-88.20%

1Y Performance

Healthcare

Sector 1Y

Diagnostics & Research

Industry 1Y

Fundamentals

Updated daily after market close

P/E ratio—

EPS (TTM)$-4.670.0% YoY

Profit margin-280.6%HEALTHCARE

Market cap$3.9MMicro cap

Valuation

Forward P/E: —
PEG ratio: —
P/B: 1.22
P/S (TTM): 0.70
EV/EBITDA: -0.21

Profitability & growth

ROE (TTM): -623.0%
Operating margin: -267.6%
Revenue growth YoY: -27.1%
Dividend yield: —
Beta: -1.33

Last earnings

May 8, 2026 · Reported $-0.81

Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

50 articles · sorted by date

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About bioAffinity Technologies, Inc.

Company profile

bioAffinity Technologies, Inc., a biotechnology company, is engaged in the development of non-invasive diagnostic tests and specific treatments for cancer. The company is headquartered in San Antonio, Texas.

Classification

Sector: Healthcare
Industry: Diagnostics & Research
Exchange: NASDAQ
Country: USA
Currency: USD

Company profile

HQ: 3300 NACOGDOCHES ROAD, SAN ANTONIO, TX
Fiscal year end: December
Latest quarter: Mar 31, 2026

Market cap$3.9M

Shares outstanding$4.7M

52W high$13.80

52W low$0.69

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer

Overview

BIAF

Market Comparison

Fundamentals

Valuation

Profitability & growth

News & Sentiment

bioAffinity Technologies (NASDAQ: BIAF) raises $3.2M in stock and pre-funded warrant sale

bioAffinity Technologies Raises $3.2M in Best-Efforts Offering, Signs Purchase and Placement Pacts

bioAffinity Technologies Announces Closing of $3.2 Million Offering

bioAffinity Technologies closes $3.2M public offering

bioAffinity sells 4M shares, raises $3.2M in public offering

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

bioAffinity (NASDAQ: BIAF) to sell 1.04M shares, up to 2.96M pre-funded warrants

BioAffinity Technologies Prices $3.2 Million Offering; Shares Drop 13%

bioAffinity Technologies prices $3.2M public offering

bioAffinity sells 4M shares, aiming to raise $3.2M

WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering

BioAffinity Technologies Prices $3.2 Million Offering; Shares Drop 13%

bioAffinity Technologies prices $3.2M public offering

bioAffinity Technologies Inc (BIAFW) Dividends & Stock Splits: Historical Payouts and Event Timeline

[EFFECT] bioAffinity Technologies, Inc. SEC Filing

bioAffinity Technologies Announces Program to Advance Veteran Lung Health: Philips, bioAffinity Technologies and 4DMedical Highlight New Approaches to Lung Health Screening for U.S. Veterans

bioAffinity (BIAF) S-1/A adds placement agency pact and warrant forms

bioAffinity Technologies to host July 21 webinar on veteran lung screening with Philips and 4DMedical

Veterans face higher lung cancer risk; new webinar explores screening tools

BioAffinity Technologies Files to Offer 2.63M Shrs or Pre-Funded Warrants

About bioAffinity Technologies, Inc.

Classification

Company profile

BIAF

Market Comparison

BIAF Market Analysis

Overview

BIAF

Market Comparison

Fundamentals

Valuation

Profitability & growth

News & Sentiment

bioAffinity Technologies (NASDAQ: BIAF) raises $3.2M in stock and pre-funded warrant sale

bioAffinity Technologies Raises $3.2M in Best-Efforts Offering, Signs Purchase and Placement Pacts

bioAffinity Technologies Announces Closing of $3.2 Million Offering

bioAffinity Technologies closes $3.2M public offering

bioAffinity sells 4M shares, raises $3.2M in public offering

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

bioAffinity (NASDAQ: BIAF) to sell 1.04M shares, up to 2.96M pre-funded warrants

BioAffinity Technologies Prices $3.2 Million Offering; Shares Drop 13%

bioAffinity Technologies prices $3.2M public offering

bioAffinity sells 4M shares, aiming to raise $3.2M

WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering

BioAffinity Technologies Prices $3.2 Million Offering; Shares Drop 13%

bioAffinity Technologies prices $3.2M public offering

bioAffinity Technologies Inc (BIAFW) Dividends & Stock Splits: Historical Payouts and Event Timeline

[EFFECT] bioAffinity Technologies, Inc. SEC Filing

bioAffinity Technologies Announces Program to Advance Veteran Lung Health: Philips, bioAffinity Technologies and 4DMedical Highlight New Approaches to Lung Health Screening for U.S. Veterans

bioAffinity (BIAF) S-1/A adds placement agency pact and warrant forms

bioAffinity Technologies to host July 21 webinar on veteran lung screening with Philips and 4DMedical

Veterans face higher lung cancer risk; new webinar explores screening tools

BioAffinity Technologies Files to Offer 2.63M Shrs or Pre-Funded Warrants

About bioAffinity Technologies, Inc.

Classification

Company profile

BIAF

Market Comparison